Skip to main content

Peer Review reports

From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease

Original Submission
9 Sep 2020 Submitted Original manuscript
1 Oct 2020 Reviewed Reviewer Report
3 Oct 2020 Reviewed Reviewer Report
1 Nov 2020 Author responded Author comments - Nattawut Wongpraparut
Resubmission - Version 2
1 Nov 2020 Submitted Manuscript version 2
2 Nov 2020 Reviewed Reviewer Report
20 Nov 2020 Reviewed Reviewer Report
15 Mar 2021 Reviewed Reviewer Report
26 Mar 2021 Reviewed Reviewer Report
29 Mar 2021 Reviewed Reviewer Report
1 May 2021 Author responded Author comments - Nattawut Wongpraparut
Resubmission - Version 3
1 May 2021 Submitted Manuscript version 3
3 May 2021 Reviewed Reviewer Report
4 May 2021 Reviewed Reviewer Report
10 May 2021 Reviewed Reviewer Report
21 May 2021 Reviewed Reviewer Report
25 May 2021 Author responded Author comments - Nattawut Wongpraparut
Resubmission - Version 4
25 May 2021 Submitted Manuscript version 4
1 Jun 2021 Reviewed Reviewer Report
1 Jun 2021 Reviewed Reviewer Report
2 Jun 2021 Reviewed Reviewer Report
23 Jun 2021 Author responded Author comments - Nattawut Wongpraparut
Resubmission - Version 5
23 Jun 2021 Submitted Manuscript version 5
Publishing
24 Jun 2021 Editorially accepted
26 Jul 2021 Article published 10.1186/s12872-021-02140-0

You can find further information about peer review here.

Back to article page